Scantox is a bronze sponsor of the upcoming Bio-Neuroscience Conference in Amsterdam this February.
This leading industry event brings together key stakeholders in CNS drug development, including biotech innovators, pharma executives, and investors, to explore the latest advancements in neuroscience.
As a trusted preclinical CRO with a strong foundation in neuropharmaceutical research, Scantox is committed to supporting scientific progress that creates real value for patients and society. Our participation reflects our dedication to accelerating the development of effective therapies that improve lives.
We look forward to insightful discussions, meaningful collaborations, and contributing to the future of neuroscience.
Meet us in Amsterdam and let’s shape the future together.
